Kazushige Wakuda
0000-0002-6369-2388
Publication & Citation Trends
Publications
0 total
Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With EGFR Mutation (West Japan Oncology Group 11719L: ADJUST Study)
Cited by 0
Semantic Scholar
Evaluation of postoperative pain by PainVision® PS-2100, a quantitative analyzer for perception and pain in pulmonary resection: a prospective pilot study
Cited by 0
Semantic Scholar
First-line (1L) datopotamab deruxtecan (Dato-DXd) + rilvegostomig in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohort 5).
Cited by 4
Semantic Scholar
Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC
Cited by 14
Semantic Scholar
Initial Patient Characteristics Associated With Ineligibility for Second‐Line Therapy After Progression on First‐Line Osimertinib in EGFR ‐Mutated Non‐Small Cell Lung Cancer
Cited by 0
Semantic Scholar
Deterioration of performance status before administration of chemotherapy as a prognostic factor in untreated advanced non-small cell lung cancer.
Cited by 0
Semantic Scholar
Phase II study of afatinib for advanced non-small cell lung cancer with uncommon epidermal growth factor receptor mutations, including compound mutations detected by next-generation sequencing
Cited by 1
Semantic Scholar
Phase 2 study of atezolizumab with carboplatin plus pemetrexed followed by maintenance atezolizumab with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: CJLSG1902.
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(113)
Lung Cancer Research Studies
(73)
Lung Cancer Diagnosis and Treatment
(41)
Cancer Immunotherapy and Biomarkers
(39)
Neuroendocrine Tumor Research Advances
(25)
Affiliations
Nihon University
Wakayama Medical University
Thoracic Surgery Foundation
Shizuoka Cancer Center
Kurashiki Central Hospital